Hartl D - Search Results

1

Current concepts: host-pathogen interactions in cystic fibrosis airways disease.

Tang AC, Turvey SE, Alves MP, Regamey N, Tümmler B, Hartl D. Tang AC, et al. Among authors: hartl d. Eur Respir Rev. 2014 Sep;23(133):320-32. doi: 10.1183/09059180.00006113. Eur Respir Rev. 2014. PMID: 25176968 Free PMC article. Review.

2

Influenza A(H1N1)pdm09 and cystic fibrosis lung disease: a systematic meta-analysis.

Renk H, Regamey N, Hartl D. Renk H, et al. Among authors: hartl d. PLoS One. 2014 Jan 10;9(1):e78583. doi: 10.1371/journal.pone.0078583. eCollection 2014. PLoS One. 2014. PMID: 24427261 Free PMC article.

3

Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis.

Latzin P, Hartl D, Regamey N, Frey U, Schoeni MH, Casaulta C. Latzin P, et al. Among authors: hartl d. Eur Respir J. 2008 Jan;31(1):36-42. doi: 10.1183/09031936.00078107. Epub 2007 Sep 26. Eur Respir J. 2008. PMID: 17898016 Free article.

4

Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity.

Kormann MSD, Dewerth A, Eichner F, Baskaran P, Hector A, Regamey N, Hartl D, Handgretinger R, Antony JS. Kormann MSD, et al. Among authors: hartl d. PLoS One. 2017 Aug 28;12(8):e0183526. doi: 10.1371/journal.pone.0183526. eCollection 2017. PLoS One. 2017. PMID: 28846703 Free PMC article.

5

An informative intragenic microsatellite marker suggests the IL-1 receptor as a genetic modifier in cystic fibrosis.

Stanke F, Hector A, Hedtfeld S, Hartl D, Griese M, Tümmler B, Mall MA. Stanke F, et al. Among authors: hartl d. Eur Respir J. 2017 Dec 28;50(6):1700426. doi: 10.1183/13993003.00426-2017. Print 2017 Dec. Eur Respir J. 2017. PMID: 29284683 Free article. No abstract available.

6

Allergic bronchopulmonary aspergillosis: the hunt for a diagnostic serological marker in cystic fibrosis patients.

Hafen GM, Hartl D, Regamey N, Casaulta C, Latzin P. Hafen GM, et al. Among authors: hartl d. Expert Rev Mol Diagn. 2009 Mar;9(2):157-64. doi: 10.1586/14737159.9.2.157. Expert Rev Mol Diagn. 2009. PMID: 19298139 Review.

7

CFTR: cystic fibrosis and beyond.

Mall MA, Hartl D. Mall MA, et al. Among authors: hartl d. Eur Respir J. 2014 Oct;44(4):1042-54. doi: 10.1183/09031936.00228013. Epub 2014 Jun 12. Eur Respir J. 2014. PMID: 24925916 Free article.

8

The chemokine CCL18 characterises Pseudomonas infections in cystic fibrosis lung disease.

Hector A, Kröner C, Carevic M, Bakele M, Rieber N, Riethmüller J, Griese M, Zissel G, Hartl D. Hector A, et al. Among authors: hartl d. Eur Respir J. 2014 Dec;44(6):1608-15. doi: 10.1183/09031936.00070014. Epub 2014 Aug 19. Eur Respir J. 2014. PMID: 25142483 Free article.

9

CXCR4+ granulocytes reflect fungal cystic fibrosis lung disease.

Carevic M, Singh A, Rieber N, Eickmeier O, Griese M, Hector A, Hartl D. Carevic M, et al. Among authors: hartl d. Eur Respir J. 2015 Aug;46(2):395-404. doi: 10.1183/09031936.00173514. Epub 2015 Apr 30. Eur Respir J. 2015. PMID: 25929952 Free article.

10

Innate immunity in cystic fibrosis lung disease.

Hartl D, Gaggar A, Bruscia E, Hector A, Marcos V, Jung A, Greene C, McElvaney G, Mall M, Döring G. Hartl D, et al. J Cyst Fibros. 2012 Sep;11(5):363-82. doi: 10.1016/j.jcf.2012.07.003. Epub 2012 Aug 20. J Cyst Fibros. 2012. PMID: 22917571 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

847 results

Search Page